
A. Keith Dunker, PhD
James Glazier, PhD
Snehasis Mukhopadhyay, PhD
Mathew Palakal, PhD
Mu Wang, PhD
Frank A. Witzmann, PhD
Address
Center for Computational Biology and Bioinformatics
Indiana University School of Medicine
Medical Information Sciences Building
410 West 10th Street
Indianapolis, IN 46202-2111
Phone: (317) 278-9220
Fax: (317) 278-9217
Email: kedunker@iupui.edu
Dr. Dunker started research in computational biology and bioinformatics in the mid-1980s and began using bioinformatics to study intrinsically disordered proteins in the mid-1990s, where he and his collaborators were the first to consider these proteins as a distinct class with important biological functions. His bioinformatics research goals over the next several years include the improvement of intrinsic disorder predictions, especially with respect to identifying different types of disorder (flavors) and then to understanding the relationships between the different types of disorder and protein function, i.e., to understand flavor-function relationships. In addition, he wants to combine bioinformatics prediction with laboratory experimentation to develop new approaches for understanding protein-protein signaling interactions that involve intrinsically disordered proteins and to develop proteomics methodologies specifically geared to uncovering the unfoldome (e.g. the set of intrinsically unfolded proteins in a given organism).
Address
Department of Physics
Swain Hall West 159
727 E 3rd St.
Indiana University, Bloomington
Bloomington, IN 47405
Phone: (812) 855-3735
Fax: (812) 855-5533
E-mail: glazier@indiana.edu
Research in my laboratory has focuses on embryonic development and the development of experimental and computational methodology for its study. We develop computer simulations to model morphogenesis (pattern-formation), including simulations of limb and vascular development, gastrulation, somitogenesis (segmentation) and tumor growth and we conduct experiments to track cell movements during these developmental phenomena using confocal microscopy. We have also developed (and continue to develop) an open-source modeling environment CompuCell3D, that makes writing even very sophisticated simulations fairly straightforward (it is available for download from https://simtk.org/home/compucell3d). We also develop biosensors to quantify protein, lipid and carbohydrate concentrations for scientific and medical applications. In addition, I organize conferences promoting interdisciplinary approaches to major biomedical issues.
Address
Department of Computer & Information Science
School of Science
Indiana University-Purdue University Indianapolis
723 W. Michigan St. SL 280J
Indianapolis, IN 46202
Phone: (317) 274-9732
Fax: (317) 274-9742
E-mail: smukhopa@iupui.edu
Understanding how human brain or other intelligent biological systems function has always been one of the holy grails of human endeavor. Recent advances in learning and adaptive systems make this goal less remote and unattainable than before. New computing paradigms such as artificial neural networks, reinforcement-based machine learning and multi-agent systems incorporate the ability to solve complex problems and make decisions in a dynamic environment in an adaptive fashion. At the same time, such intelligent systems have found wide-spread applications in many practical areas such as control of man-made engineering systems, management of information in digital libraries, and ?filtering and analysis of biological information. Our intelligent systems research group in the Computer and Information Science department at IUPUI has been active in furthering the progress of this field both in terms of the basic research as well as applications in important scientific and engineering problems. The basic research directions include learning and adaptation in multi-agent intelligent systems and decentralized adaptive control in distributed systems. Methods have been developed to achieve optimal or near-optimal performance, while minimizing communication overhead and dealing with uncertainties in a stable fashion. Application areas under investigation include filtering, delivery, and analysis of information in biological and other domains such as digital libraries. The primary objective of information filtering is to identify, in a large information collection, items that are relevant according to some criteria. Following this, the identified relevant information can be further analyzed with the objective of extracting high-level knowledge such as object-object associations. We have successfully developed learning approaches based on neural networks and reinforcement learning to both theses problems of filtering and analysis of data.
Address
School of Informatics
Indiana University-Purdue University Indianapolis
535 W. Michigan St. IT 475
Indianapolis, IN 46202
Phone: (317) 278-7689
Fax: (317) 278-4140
Email: mpalakal@cs.iupui.edu
The biomedical literature databases continue to grow rapidly with vital information that is important for conducting sound biomedical research. BioMap is an attempt to create a scalable knowledgebase of biological relationships from vast amount of literature data. The development of BioMap system addresses several innovative research issues related to knowledge discovery from literature documents and real-time, interactive access of this knowledge. Specific problems that are being investigated are: identification of multiple biological objects and discovering their direct, transitive and directional relationships and generating pathways of new hypothesis using the hypergraph based on graph algorithms. Protein-protein, gene-protein, disease-drug interactions are examples of biological associations that are automatically discovered from large number of literature documents. These associations are further validated using computational techniques. BioMap can discover interactions in specific biomedical problem domains such as inflammatory diseases, regenerative biology, and cancer.
Address
Department of Biochemistry and Molecular Biology
Indiana University School of Medicine
Indiana University-Purdue University Indianapolis
Biotechnology Research and Training Center
1345 W. 16th St, Room 312
Indianapolis, IN 46202
Phone: (317) 278-0296; (317) 274-1446 (INCAPS)
Fax: (317) 278-9739
Email: muwang@iupui.edu
1. Molecular Mechanisms of DNA Damage and Repair
Damage to DNA is an important etiologic pathway for a number of important processes such as cancer, birth defects and aging. Therefore understanding DNA repair pathways is very important. One of my research interests is to study DNA repair mechanisms in both normal and repair deficient mammalian cell lines. We have developed a method for monitoring the interactions between DNA repair proteins and damaged DNA using surface plasmon resonance (SPR) technology, and we are able to make DNA containing different types of damage produced by selected mutagenic and carcinogenic agents such as UV and cisplatin. By using DNA substrates containing site specific adducts, we have been able to determine the preference in DNA binding activity for DNA repair proteins on damaged DNA. Understanding the mechanism of DNA repair pathway will help development of gene therapy as well as chemotherapy of the DNA repair-deficient diseases such as xeroderma pigmentosum (XP). In addition, we are also interested in studying Fanconi anemia (FA), a disorder characterized by bone marrow failure and development of leukemia and other malignancies, in which there is a marked hypersensitivity to DNA interstrand cross linking agents. To date, eleven complementation groups (FA-A to FA-L) have been identified. However, the function of each complementing protein remains largely unknown. We are particularly interested in studying the interactions of FA proteins with other DNA repair proteins using both molecular biology and bioanalytic chemistry techniques. With recent advancement of proteomic technologies, mass spectrometry will be the main tool applied for identification of proteins that interact with FA proteins. The goal of our study is to test 1) whether these FA proteins form complex at the damaged site on DNA, either with each other or with other DNA repair proteins, and 2) what is the role of each protein in damage recognition and/or DNA repair processes.
2. Biomarkers for Cisplatin Resistance in Human Tumor Cells using Proteomics
Platinum-based chemotherapy is still the primary treatment for many types of cancer. Most patients with the disease are initially responsive to chemotherapeutic treatment. However, the majority of cancer patients eventually relapse and become refractory to additional treatment. This drug-resistance is a major impediment to the successful treatment of cancer. To date the mechanisms of drug-resistance are poorly understood. Previous studies have suggested that many proteins, such as BRCA1, BRCA2, MDR1, MRP1, MDM2, hMLH1, HSP27, and HSP70, are differentially expressed in drug-resistant tumor cells, such as ovarian tumor cells, by mRNA differential display analysis. However, global protein pattern changes in these tumor cells have not yet been demonstrated. With recent developments in electrophoresis, imaging, and mass spectrometric technologies, along with the explosion in genomic and protein bioinformatics, the complex status of protein expression, defined as “expression” proteomics, can be analyzed. It is possible to examine, at the molecular level, the perturbations of physiological processes, as well as mechanisms of disease, injury, and therapeutic intervention, by profiling the proteins comprising the organellar, cellular, or extracellular proteomes. Proteomics has provided a very important tool to revolutionize disease diagnosis, drug target discovery, and new therapeutic development.
Since there is no established protein expression profile between drug-sensitive and -resistant ovarian cancer cells, we will choose established ovarian cancer cell lines as the model system for our investigation. We will apply the cutting-edge proteomic technologies such as MudPIT and Label-free Protein Quantification to identify novel proteins associated with cisplatin-resistance in human ovarian cancer cells and thus define new therapeutic targets in ovarian cancer intervention. Once new targets are identified by proteomics, we will develop a strategy to modulate the expression of particular proteins, and then evaluate whether this strategy can lead to the reversal of cisplatin sensitivity of the ovarian cancer cells.
Along the way, we will develop a strategy for subcellular fractionation of lysates obtained from ovarian cancer cells in order to increase depth-of-field (protein dynamic range). Application of this strategy will enhance our ability to examine low abundance proteins in the whole cell lysates. Each fraction will be quantitatively analyzed by quantitative mass spectrometry. Our work will provide important information about biomarkers for drug-resistance in ovarian cancer cells. Identification of biomarker(s) for cisplatin-resistance in ovarian cancer cells and modulation of these biomarkers' expression levels will be clinically significant for finding potential therapeutic targets to develop antitumor drugs and control tumor growth.
Address
Biotechnology Research & Training Center
Indiana University School of Medicine
1345 W. 16th Street, Room 308
Indianapolis, IN 46204
Phone: (317) 278-5741
Fax: (317) 278-9739
Email: fwitzman@iupui.edu
My research involves the application of proteomic techniques to the detection and analysis of protein expression in a variety of research paradigms. Specific projects include 1) differential protein expression by cells and tissues exposed to toxic agents in vivo or in vitro, 2) alcohol effects on protein expression in various brain cell types/regions 3) characterization of serum proteins associated with atherosclerosis, diabetic dyslipidemia, and alcoholism, and 4) improving gel-based proteomics by developing sample preparation and prefractionation strategies. In conducting these studies, we apply solution IEF, large format one- and two-dimensional gel electrophoretic separations and image analysis, MALDI-TOF MS, and tandem mass spectrometry (LC-MS/MS). Protein expression information obtained in this way can be used as indicators or “molecular biomarkers” of primary or secondary cellular effects, or used to better understand the molecular mechanisms that trigger altered or impaired physiological function.
Department of Biology, School of Science
Indiana University-Purdue University Indianapolis (IUPUI)
SL 306, 723 West Michigan Street
Indianapolis, IN 46202-5191
Dr. David L. Stocum, Director
Tel: (317) 274-0627
dstocum@iupui.edu